116 related articles for article (PubMed ID: 32316815)
1. PD-1 blockade for disseminated Kaposi sarcoma in a patient with atopic dermatitis and chronic CD8 lymphopenia.
Gambichler T; Susok L
Immunotherapy; 2020 May; 12(7):451-457. PubMed ID: 32316815
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma during immunosuppressive therapy for atopic dermatitis.
Vandercam B; Lachapelle JM; Janssens P; Tennstedt D; Lambert M
Dermatology; 1997; 194(2):180-2. PubMed ID: 9094472
[TBL] [Abstract][Full Text] [Related]
3. PD-1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma.
Scheinberg T; Lomax A; Tattersall M; Thomas D; McCowage G; Sullivan M; Karim R; Luk PP; Mahar A; Bonar F; Bhadri VA
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1327. PubMed ID: 33314769
[TBL] [Abstract][Full Text] [Related]
4. Successful Treatment of HIV-Associated Kaposi Sarcoma with Immune Checkpoint Blockade.
Galanina N; Goodman AM; Cohen PR; Frampton GM; Kurzrock R
Cancer Immunol Res; 2018 Oct; 6(10):1129-1135. PubMed ID: 30194084
[TBL] [Abstract][Full Text] [Related]
5. Kaposi sarcoma in an patient with atopic dermatitis treated with ciclosporin.
Wall D; McMenamin M; O'Mahony D; Irvine AD
BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24265347
[TBL] [Abstract][Full Text] [Related]
6. Thymoma associated with CD4+ lymphopenia, cytomegalovirus infection, and Kaposi's sarcoma.
Moysset I; Lloreta J; Miguel A; Vadell C; Ribalta T; Estrach T; Serrano S
Hum Pathol; 1997 Oct; 28(10):1211-3. PubMed ID: 9343330
[TBL] [Abstract][Full Text] [Related]
7. Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugs.
Bakker DS; Garritsen FM; Leavis HL; van der Schaft J; Bruijnzeel-Koomen CAFM; van den Broek MPH; de Bruin-Weller MS
J Dermatolog Treat; 2018 Nov; 29(7):682-687. PubMed ID: 29526121
[TBL] [Abstract][Full Text] [Related]
8. Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma.
Domingo-Musibay E; Murugan P; Giubellino A; Sharma S; Steinberger D; Yuan J; Hunt MA; Lou E; Miller JS
J Immunother Cancer; 2018 Jun; 6(1):58. PubMed ID: 29914578
[TBL] [Abstract][Full Text] [Related]
9. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
[TBL] [Abstract][Full Text] [Related]
10. A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer.
Ho AY; Barker CA; Arnold BB; Powell SN; Hu ZI; Gucalp A; Lebron-Zapata L; Wen HY; Kallman C; D'Agnolo A; Zhang Z; Flynn J; Dunn SA; McArthur HL
Cancer; 2020 Feb; 126(4):850-860. PubMed ID: 31747077
[TBL] [Abstract][Full Text] [Related]
11. Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab.
Keung EZ; Burgess M; Salazar R; Parra ER; Rodrigues-Canales J; Bolejack V; Van Tine BA; Schuetze SM; Attia S; Riedel RF; Hu J; Okuno SH; Priebat DA; Movva S; Davis LE; Reed DR; Reuben A; Roland CL; Reinke D; Lazar AJ; Wang WL; Wargo JA; Tawbi HA
Clin Cancer Res; 2020 Mar; 26(6):1258-1266. PubMed ID: 31900276
[TBL] [Abstract][Full Text] [Related]
12. Proliferative CD8(+) PD-1(+) T-cell infiltration in a pembrolizumab-induced cutaneous adverse reaction.
Kunimasa K; Isei T; Nakamura H; Kimura M; Inoue T; Tamiya M; Nishino K; Kumagai T; Nakatsuka SI; Endo H; Inoue M; Imamura F
Invest New Drugs; 2018 Dec; 36(6):1138-1142. PubMed ID: 29947012
[TBL] [Abstract][Full Text] [Related]
13. Rare and fatal complication of immune checkpoint inhibition: a case report of haemophagocytic lymphohistiocytosis with severe lichenoid dermatitis.
Choi S; Zhou M; Bahrani E; Martin BA; Ganjoo KN; Zaba LC
Br J Haematol; 2021 Jun; 193(6):e44-e47. PubMed ID: 33954981
[No Abstract] [Full Text] [Related]
14. Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial.
Jabbour SK; Berman AT; Decker RH; Lin Y; Feigenberg SJ; Gettinger SN; Aggarwal C; Langer CJ; Simone CB; Bradley JD; Aisner J; Malhotra J
JAMA Oncol; 2020 Jun; 6(6):848-855. PubMed ID: 32077891
[TBL] [Abstract][Full Text] [Related]
15. Possible Pseudo-progression of Non-small Cell Lung Carcinoma in a Patient With Clinical Hyper-progression Associated With Trousseau Syndrome Who Was Treated With Pembrolizumab: A Case Report.
Shionoya Y; Hirohashi Y; Takahashi H; Hashimoto M; Nishiyama K; Takakuwa Y; Nakatsugawa M; Kubo T; Kanaseki T; Tsukahara T; Torigoe T
Anticancer Res; 2021 Jul; 41(7):3699-3706. PubMed ID: 34230169
[TBL] [Abstract][Full Text] [Related]
16. Effective Response of Intrahepatic Cholangiocarcinoma to Pembrolizumab: A Case Report.
Nakamura M; Ueno M; Hayami S; Kawai M; Miyamoto A; Suzaki N; Hirono S; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Kojima F; Yamaue H
Anticancer Res; 2020 Jul; 40(7):4123-4129. PubMed ID: 32620661
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.
Suriyo T; Fuangthong M; Artpradit C; Ungtrakul T; Sricharunrat T; Taha F; Satayavivad J
Eur J Pharmacol; 2021 Apr; 897():173960. PubMed ID: 33617828
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical Trial.
Arrieta O; Barrón F; Ramírez-Tirado LA; Zatarain-Barrón ZL; Cardona AF; Díaz-García D; Yamamoto Ramos M; Mota-Vega B; Carmona A; Peralta Álvarez MP; Bautista Y; Aldaco F; Gerson R; Rolfo C; Rosell R
JAMA Oncol; 2020 Jun; 6(6):856-864. PubMed ID: 32271354
[TBL] [Abstract][Full Text] [Related]
19. Case of metastatic kaposi sarcoma successfully treated with anti-PD-1 immunotherapy.
Cesmeci E; Guven DC; Aktas BY; Aksoy S
J Oncol Pharm Pract; 2021 Oct; 27(7):1766-1769. PubMed ID: 33427037
[TBL] [Abstract][Full Text] [Related]
20. Asymptomatic Pulmonary Allograft Kaposi Sarcoma: A Case Report.
Nannini N; Rebusso A; Lunardi F; Loy M; Calabrese F; Battistella L; Schiavon M; Rea F; Calabrese F
Exp Clin Transplant; 2017 Aug; 15(4):477-479. PubMed ID: 26767437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
